Riskpilot← Back to searchSign inGet full accessLEGEVAKT X AS
ASActiveOrg 922811202Blichs Gate 3, 3044 DrammenTour operator activities · NACE 7912Est. 20190 employees
Revenue 2024
NOK 239K
-10% vs 2023
EBITDA margin
-79.4%
+60% vs 2023
Equity ratio
95.8%
Financial strength
Net profit 2024
NOK -289K
+51% vs 2023
| Revenue | NOK 239K | -10% |
| EBITDA | NOK -190K | +60% |
| Net profit | NOK -289K | +51% |
| Total assets | NOK 1,6M | -10% |
| Equity | NOK 1,5M | -13% |
| Employees | 0 | — |
Legal name
LEGEVAKT X AS
Org number
922811202
Legal form
Aksjeselskap
NACE code
7912 · Tour operator activities
Founded
27. mai 2019
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Helsetjenester, herunder legevakt og andre helserelaterte tjenester.
Address
Blichs Gate 3, 3044 Drammen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 635 | 15 416 | 4 348 | 265 | 239 |
| Staff expenses | −0 | −76 | −0 | −12 | −0 |
| EBITDA | 1 200 | 7 155 | 241 | −474 | −190 |
| Depreciation & amort. | −26 | −31 | −88 | −121 | −116 |
| EBIT | 1 174 | 7 124 | 153 | −596 | −306 |
| Net financials | −40 | −0 | −11 | 1 | −0 |
| Profit before tax | 1 134 | 7 124 | 142 | −595 | −306 |
| Tax | 249 | 1 695 | 27 | −10 | −16 |
| Net profit | 884 | 5 429 | 115 | −585 | −289 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 042 | 8 539 | 2 353 | 1 760 | 1 577 |
| Equity | 783 | 2 212 | 2 327 | 1 742 | 1 511 |
| Long-term debt | 20 | 8 | 10 | 0 | 0 |
| Short-term debt | 240 | 6 320 | 17 | 18 | 66 |
| Total debt | 260 | 6 328 | 26 | 18 | 66 |
EBITDA margin
-79.4%
This company
15.8%
Market median
-603% vs market
20202024
Equity ratio
95.8%
This company
38.2%
Market median
+151% vs market
20202024
Return on equity
-19.2%
This company
18.4%
Market median
-204% vs market
20202024
Net profit margin
-121.1%
This company
8.1%
Market median
-1595% vs market
20202024
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CS Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
CK Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Chairman | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
AH | Board of Directors | 2022 – 2023 |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Individual | 16.5% | 16.5% | 2022 | |
| Company | 5.5% | 5.5% | 2022 | |
| Company | 2% | 2% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
X Force As
LEGEVAKT X AS Board members of LEGEVAKT X AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Chong Kit Ronny Shek | Chief Executive Officer | 0 companies |
| Chong Shing Henry Shek | Chief Executive Officer | 0 companies |
| Khang Hy Van Huynh | Chairman | 0 companies |
| Kristoffer Grong | Board of Directors | 0 companies |
| Alex Hsi | Board of Directors | 0 companies |